| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |